116 related articles for article (PubMed ID: 38306567)
41. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
He J; Zhang W; Li F; Yu Y
Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
[TBL] [Abstract][Full Text] [Related]
42. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
44. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
45. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
Zhou J; Wang X; Li Z; Jiang R
FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
[TBL] [Abstract][Full Text] [Related]
46. WT1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments.
Jia M; Shi Y; Xie Y; Li W; Deng J; Fu D; Bai J; Ma Y; Zuberi Z; Li J; Li Z
Cells; 2021 Dec; 11(1):. PubMed ID: 35011587
[TBL] [Abstract][Full Text] [Related]
47. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X
J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519
[TBL] [Abstract][Full Text] [Related]
48. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
[TBL] [Abstract][Full Text] [Related]
49. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
Fan K; Zhang BH; Han D; Sun YC
BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
[TBL] [Abstract][Full Text] [Related]
50. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma.
Li S; Sun X; Miao S; Lu T; Wang Y; Liu J; Jiao W
Thorac Cancer; 2018 Aug; 9(8):924-930. PubMed ID: 29932500
[TBL] [Abstract][Full Text] [Related]
51. High GJB2 mRNA expression and its prognostic significance in lung adenocarcinoma: a study based on the TCGA database.
Tang Y; Zhang YJ; Wu ZH
Medicine (Baltimore); 2020 Apr; 99(14):e19054. PubMed ID: 32243356
[TBL] [Abstract][Full Text] [Related]
52. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
Li X; Shi Y; Yin Z; Xue X; Zhou B
J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
[TBL] [Abstract][Full Text] [Related]
53. Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma.
You J; Fang W; Zhao Q; Chen L; Chen L; Chen F
Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739047
[TBL] [Abstract][Full Text] [Related]
54. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
55. Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population.
Xie Y; Wu H; Hu W; Zhang H; Li A; Zhang Z; Ren S; Zhang X
Pathol Oncol Res; 2022; 28():1610455. PubMed ID: 36032660
[No Abstract] [Full Text] [Related]
56. Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.
Liu R; Guo Z; Huang J; Li J; Tan Q; Luo Q
Exp Biol Med (Maywood); 2022 Apr; 247(8):641-657. PubMed ID: 35068222
[TBL] [Abstract][Full Text] [Related]
57. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY
FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256
[TBL] [Abstract][Full Text] [Related]
58. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
59. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
[TBL] [Abstract][Full Text] [Related]
60. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
Yu L; Qiao R; Xu J; Han B; Zhong R
Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]